KAHA ligation as a platform for the rapid discovery of Protein Tyrosine phosphatase 1B (PTP1B) inhibitors
- Bioorg Chem. 2025 Jan:154:108028. doi: 10.1016/j.bioorg.2024.108028.
- 1. School of Pharmaceutical Science and Technology (SPST), Tianjin University, Tianjin 300072, PR China; Key Laboratory for Tibet Plateau Phytochemistry of Qinghai Province, College of Pharmacy, Qinghai Minzu University, Xining 810007, PR China.
- 2. School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of SunYat-sen University, Shenzhen 518107, PR China.
- 3. Singapore Eye Research Institute (SERI), The Academia, 20 College Road, Discovery Tower, Singapore 169856, Singapore.
- 4. School of Pharmaceutical Science and Technology (SPST), Tianjin University, Tianjin 300072, PR China; Singapore Eye Research Institute (SERI), The Academia, 20 College Road, Discovery Tower, Singapore 169856, Singapore.
We have successfully designed and assembled a 66-member library of Protein tyrosine phosphatases (PTP) inhibitor candidates using α-ketoacid-hydroxylamine (KAHA) ligation. Subsequent in situ enzymatic screening revealed a potent hit (IC50 = 1.67 μM) against PTP1B, which displayed 6.8- to 50-fold selectivity over Other phosphatases.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: PhosphataseResearch Areas: Metabolic Disease